Paul Campanelli, Executive VP, Pres-Generics Division at PAR PHARMACEUTICAL COMPANIES, INC. (PRX), bought 2,100 shares at $18.19 ($38K) on 2007-10-03, disclosed to the SEC on 2007-10-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ENDP | BUY | 2016-05-11 | $202K | — | Filing → |
| ENDP | BUY | 2015-11-12 | $117K | — | Filing → |
| PRX | SELL | 2011-03-09 | $1.5M | — | Filing → |